What's Next for PrEP: New Strategies for HIV Prevention

Publish date:
June 05, 2023
New England AETC Graphic Identity
AETC Source
New England AETC
CE credit may be available.

(Recorded 5/24/23)

register to access the recording

Just over 10 years ago, the first agent for HIV pre-exposure prophylaxis (PrEP) was approved in the United States. Since then, the landscape of PrEP has shifted, with the approval of additional PrEP medications and the growth of low-threshold PrEP delivery strategies, such as same-day PrEP. This interactive webinar reviews new medications in the pipeline for PrEP and emerging PrEP delivery models.  

This session offers 1.0 credit of CME. 

Browse more